Search results for "LOAD"

showing 10 items of 1967 documents

Training load does not affect detraining's effect on muscle volume, muscle strength and functional capacity among older adults

2017

Research underlines the potential of low-load resistance exercise in older adults. However, while the effects of detraining from high-load protocols have been established, it is not known whether gains from low-load training would be better/worse maintained. The current study evaluated the effects of 24weeks of detraining that followed 12weeks of high- and low-load resistance exercise in older adults. Fifty-six older adults (68.0±5.0years) were randomly assigned to leg press and leg extension training at either HIGH load (2×10-15 repetitions at 80% of one-repetition maximum (1-RM)), LOW load (1×80-100 repetitions at 20% of 1-RM), or LOW+ load (1×60 repetitions at 20% of 1-RM, immediately fo…

MaleAgingTime FactorsvanhuksetlihaksetIsometric exerciseliikuntaResistance Training/methodsBiochemistryMuscle hypertrophyphysical training0302 clinical medicineEndocrinologyBelgiumstrength trainingTraining loadLeg pressta315senior citizensAge FactorsOrgan SizeMiddle AgedAdaptation Physiologicalmuscle massMuscle FatigueFemalevoimaharjoittelumusclesikääntyneetmedicine.medical_specialtyMuscle Skeletal/diagnostic imagingMuscle volumeAffect (psychology)elderlysarcopenia03 medical and health sciencesPhysical medicine and rehabilitationGeneticsmedicineHumansMuscle Strengthmuscle hypertrophyMuscle SkeletalMolecular BiologyGeriatric AssessmentAgedbusiness.industryResistance trainingResistance Training030229 sport sciencesCell BiologyHypertrophymedicine.diseaseAgeingresistance exerciselihasmassaSarcopeniaPhysical therapyExercise TestbusinessTomography X-Ray Computed030217 neurology & neurosurgeryExperimental Gerontology
researchProduct

Effects of Combined Strength and Endurance Training on Treadmill Load Carrying Walking Performance in Aging Men

2010

Holviala, J, Hakkinen, A, Karavirta, L, Nyman, K, Izquierdo, M, Gorostiaga, EM, Avela, J, Korhonen, J, Knuutila, V-P, Kraemer, WJ, and Hakkinen, K. Effects of combined strength and endurance training on treadmill load carrying walking performance in aging men. J Strength Cond Res 24(6): 1584-1595, 2010—The present study examined the effects of twice weekly total body strength training (ST), endurance cycling (ET), and combined ST and ET (2 + 2 times a week) (SET) training on the load carrying walking test performance on the treadmill (TM) and changes in neuromuscular and endurance performance during a 21-week training period in aging men. Forty healthy men (54.8 6 8.0 years) were divided in…

MaleAgingmedicine.medical_specialtyStrength trainingPhysical Therapy Sports Therapy and RehabilitationWalkingIsometric exerciseBody Mass IndexVertical jumpOxygen ConsumptionPhysical medicine and rehabilitationHeart RateEndurance trainingHeart ratemedicineHumansOrthopedics and Sports MedicineLactic AcidMuscle StrengthTreadmillMuscle SkeletalAgedLegbusiness.industryVO2 maxResistance TrainingGeneral MedicineMiddle AgedAdaptation PhysiologicalLoad carryingForearmExercise TestPhysical EndurancePhysical therapybusinessJournal of Strength and Conditioning Research
researchProduct

Antiretroviral therapy abrogates association between arginase activity and HIV disease severity

2010

AbstractArginase-induced L-arginine deprivation is emerging as a key mechanism for the downregulation of immune responses. We hypothesised that arginase activity increases with disease severity in HIV-seropositive patients. Our results show that peripheral blood mononuclear cells (PBMCs) from 23 HIV-seropositive patients with low CD4+ T cell counts (≤350 cells/μl) expressed significantly more arginase compared with 21 patients with high CD4+ T cell counts. Furthermore, we found a significant association between the two principal prognostic markers used to monitor HIV disease (CD4+ T cell count and plasma viral load) and PBMC arginase activity in antiretroviral therapy naïve patients but not…

MaleAnti-HIV AgentsT cellT cellsCD4 cell countL-arginineHIV InfectionsArgininePeripheral blood mononuclear cellSeverity of Illness Index03 medical and health sciences0302 clinical medicineImmune systemImmunopathologymedicineHumansImmune response030304 developmental biology0303 health sciencesbiologyArginasebusiness.industryPublic Health Environmental and Occupational HealthHIVGeneral MedicineViral Loadbiology.organism_classification3. Good healthCD4 Lymphocyte CountArginaseInfectious Diseasesmedicine.anatomical_structureSociety Meeting PaperLentivirusImmunologyHIV-1Leukocytes MononuclearParasitologyFemaleViral diseasebusinessViral load030217 neurology & neurosurgeryTransactions of the Royal Society of Tropical Medicine and Hygiene
researchProduct

NeuPAT: an intranet database supporting translational research in neuroblastic tumors.

2013

Translational research in oncology is directed mainly towards establishing a better risk stratification and searching for appropriate therapeutic targets. This research generates a tremendous amount of complex clinical and biological data needing speedy and effective management. The authors describe the design, implementation and early experiences of a computer-aided system for the integration and management of data for neuroblastoma patients. NeuPAT facilitates clinical and translational research, minimizes the workload in consolidating the information, reduces errors and increases correlation of data through extensive coding. This design can also be applied to other tumor types.

MaleBiological dataIntranetDatabases Factualbusiness.industryHealth InformaticsEffective managementWorkloadTranslational researchBioinformaticsNeuroblastic TumorData scienceComputer Science ApplicationsTranslational Research BiomedicalComputer Communication NetworksNeuroblastomaRisk stratificationMedicineHumansFemalebusinessCoding (social sciences)Computers in biology and medicine
researchProduct

Psychophysiological responses of junior orienteers under competitive pressure

2018

The purpose of the study was to examine psychobiosocial states, cognitive functions, endocrine responses (i.e., salivary cortisol and chromogranin A), and performance under competitive pressure in orienteering athletes. The study was grounded in the individual zones of optimal functioning (IZOF) and biopsychosocial models. Fourteen junior orienteering athletes (7 girls and 7 boys), ranging in age from 15 to 20 years (M = 16.93, SD = 1.77) took part in a two-day competitive event. To enhance competitive pressure, emphasis was placed on the importance of the competition and race outcome. Psychophysiological and performance data were collected at several points before, during, and after the ra…

MaleBiopsychosocial modelHydrocortisoneVisionjunior sportsEmotionsSocial Scienceslcsh:MedicineOrienteeringkilpaurheiluBiochemistryCortisolRunningcompetitive sportsCognitionLearning and Memory0302 clinical medicinePsychologyAttentionLipid HormonesYoung adultlcsh:Scienceta315psychological strainorienteeringta515Multidisciplinarybiology05 social sciencesCognitive flexibilityCognitionorienteersSports Sciencepsykofysiologiapsyykkinen kuormittavuusphysical strainsuunnistusSensory PerceptionFemalePsychologyResearch ArticleSportsClinical psychologyCompetitive BehaviorjunioriurheiluAdolescentDysfunctional family050105 experimental psychologyYoung Adult03 medical and health sciencesMemoryHumans0501 psychology and cognitive sciencespsychophysiologySalivaBehaviorSteroid HormonesAthleteslcsh:RCognitive PsychologysuunnistajatBiology and Life Sciences030229 sport sciencesbiology.organism_classificationHormonesfyysinen kuormittavuusAthletesRecreationCognitive ScienceChromogranin APerceptionlcsh:QStress PsychologicalCognitive loadNeurosciencePLOS ONE
researchProduct

Periosteal repair of the dorsal calcaneocuboid ligament: a comparative biomechanical study.

2007

Background: Isolated lateral calcaneocuboid joint instability rarely is described. Missed or delayed diagnosis resulting in inadequate treatment may lead to chronic instability, followed by sports inability and handicap in daily life. Besides arthrodesis, anatomic repair augmenting the elongated dorsal calcaneocuboid ligament with a local periosteal flap has recently been described for treatment. Methods: In a controlled laboratory study, eight isolated fresh-frozen human cadaver calcaneocuboid specimens were strained in a varus direction until failure of the dorsal calcaneocuboid ligaments. Then the dorsal calcaneocuboid ligaments were reconstructed with free periosteal flaps and tensile …

MaleCalcaneocuboid jointArthrodesismedicine.medical_treatmentDelayed diagnosisTarsal JointsSurgical Flaps03 medical and health sciences0302 clinical medicinePeriosteumLoad to failuremedicineCadaverHumansOrthopedics and Sports MedicineAged030203 arthritis & rheumatologyAged 80 and overbusiness.industry030229 sport sciencesInitial stabilityAnatomyBiomechanical Phenomenamedicine.anatomical_structureLigaments ArticularUltimate stressLigamentSurgeryFemalebusinessDorsal calcaneocuboid ligamentFootankle international
researchProduct

The Major Virus-Producing Cell Type during Murine Cytomegalovirus Infection, the Hepatocyte, Is Not the Source of Virus Dissemination in the Host

2008

SummaryThe course of systemic viral infections is determined by the virus productivity of infected cell types and the efficiency of virus dissemination throughout the host. Here, we used a cell-type-specific virus labeling system to quantitatively track virus progeny during murine cytomegalovirus infection. We infected mice that expressed Cre recombinase selectively in vascular endothelial cells or hepatocytes with a murine cytomegalovirus for which Cre-mediated recombination would generate a fluorescently labeled virus. We showed that endothelial cells and hepatocytes produced virus after direct infection. However, in the liver, the main contributor to viral load in the mouse, most viruses…

MaleCancer ResearchCell typeMuromegalovirusMICROBIOvirusesGreen Fluorescent ProteinsCongenital cytomegalovirus infectionCre recombinaseViral transformationMice TransgenicBiologyVirus ReplicationMicrobiologyVirusMicrobiologyCell LineMiceImmunology and Microbiology(all)VirologymedicineAnimalsMolecular BiologyRecombination GeneticIntegrasesViral cultureEndothelial CellsHerpesviridae InfectionsFibroblastsmedicine.diseaseVirologyMice Inbred C57BLmedicine.anatomical_structureLiverHepatocyteHepatocytesParasitologyFemaleCELLBIOViral loadCell Host & Microbe
researchProduct

Time flies when you maximize - Maximizers and satisficers perceive time differently when making decisions

2013

Three experiments assessed whether maximizing and satisficing decision-making types were associated with differences in perception of time, as a consequence of their different cognitive workloads. Findings showed that maximizers and satisficers perceived time differently during decision-making, but not during other tasks. In particular, compared to satisficers, maximizers tended to underestimate time while choosing, independently of the number of options and the specific task requirements. Satisficers instead tended to underestimate time only when the number of options or the task requirements were more challenging. Our findings suggest that the perception of time may serve as a measure of …

MaleChoice overloadProcess (engineering)Decision MakingTime perceptionExperimental and Cognitive PsychologyCognitionGeneral MedicineTime perceptionMaximizingTask (project management)Young AdultCognitionArts and Humanities (miscellaneous)Developmental and Educational PsychologySatisficingHumansSatisficingFemaleCognitive workloadPsychologyMaximizing Satisficing Time perception Choice overloadSocial psychologyCognitive psychology
researchProduct

Factors that predict response of patients with hepatitis C virus infection to boceprevir

2012

Background & Aims Little is known about factors associated with a sustained virologic response (SVR) among patients with hepatitis C virus (HCV) infection to treatment with protease inhibitors. Methods Previously untreated patients (from the Serine Protease Inhibitor Therapy 2 [SPRINT-2] trial) and those who did not respond to prior therapy (from the Retreatment with HCV Serine Protease Inhibitor Boceprevir and PegIntron/Rebetol 2 [RESPOND-2] trial) received either a combination of peginterferon and ribavirin for 48 weeks or boceprevir, peginterferon, and ribavirin (triple therapy) after 4 weeks of peginterferon and ribavirin (total treatment duration, 28–48 wk). A good response to interfer…

MaleCirrhosisMESH: Logistic ModelsHepacivirusMESH: Risk AssessmentGastroenterologyPolyethylene GlycolsMESH: Recombinant ProteinsMESH: Genotype0302 clinical medicineOdds RatioProspective StudiesMESH: Treatment OutcomeResponse to Therapy0303 health sciencesMESH: Polymorphism Single NucleotideGastroenterologyvirus diseases3. Good healthMESH: RNA ViralHCVDrug Therapy Combination030211 gastroenterology & hepatologyClinical Trial; Genetic; Prognostic Factors; Response to Therapy; Adult; Antiviral Agents; Biomarkers; Canada; Drug Therapy Combination; Europe; Female; Genotype; Hepacivirus; Hepatitis C; Humans; Interferon-alpha; Interleukins; Logistic Models; Male; Multivariate Analysis; Odds Ratio; Phenotype; Polyethylene Glycols; Polymorphism Single Nucleotide; Proline; Prospective Studies; RNA Viral; Recombinant Proteins; Ribavirin; Risk Assessment; Risk Factors; Time Factors; Treatment Outcome; United States; Viral Load; GastroenterologyViral loadmedicine.medical_specialtyMESH: InterleukinsGenotypeProlineInterferon alpha-2MESH: PhenotypeAntiviral AgentsRisk Assessment03 medical and health sciencesDrug TherapyGeneticMESH: RibavirinMESH: CanadaBoceprevirHumansPolymorphismMESH: ProlineMESH: HumansPrognostic FactorsInterleukinsMESH: AdultOdds ratiomedicine.diseaseUnited Statesdigestive system diseasesClinical trialLogistic ModelschemistryImmunologyMESH: FemaleBiomarkersTime Factorsmedicine.disease_causechemistry.chemical_compoundRisk FactorsInterferonMESH: Risk FactorsMESH: HepacivirusViralSingle NucleotideViral LoadHepatitis CClinical TrialRecombinant ProteinsEuropePhenotypeTreatment OutcomeCombinationRNA ViralFemaleMESH: Interferon-alphaMESH: Viral Loadmedicine.drugAdultMESH: Antiviral AgentsCanadaHepatitis C virusPolymorphism Single NucleotideMESH: Multivariate AnalysisInternal medicineRibavirinmedicineMESH: United States030304 developmental biologyMESH: Hepatitis CHepatologybusiness.industryRibavirinMESH: Time FactorsMESH: Biological MarkersInterferon-alpha[SDV.MHEP.HEG]Life Sciences [q-bio]/Human health and pathology/Hépatology and GastroenterologyMESH: Prospective StudiesMESH: MaleMESH: Odds RatioMESH: Drug Therapy CombinationMESH: Polyethylene GlycolsMultivariate AnalysisRNAInterferonsMESH: Europebusiness
researchProduct

Effectiveness and safety of ombitasvir, paritaprevir, ritonavir ± dasabuvir ± ribavirin: An early access programme for Spanish patients with genotype…

2017

Over the last 5 years, therapies for hepatitis C virus (HCV) infection have improved significantly, achieving sustained virologic response (SVR) rates of up to 100% in clinical trials in patients with HCV genotype 1. We investigated the effectiveness and safety of ombitasvir/paritaprevir/ritonavir +/- dasabuvir in an early access programme. This was a retrospective, multicentre, national study that included 291 treatment-naive and treatment-experienced patients with genotype 1 or 4 HCV infection. Most patients (65.3%) were male, and the mean age was 57.5years. The mean baseline viral load was 6.1 log, 69.8% had HCV 1b genotype, 72.9% had cirrhosis and 34.7% were treatment-naive. SVR at 12 w…

MaleCirrhosisSustained Virologic ResponseHepacivirusmedicine.disease_causechemistry.chemical_compound0302 clinical medicinesevere fibrosisdasabuvirMedicineAged 80 and overMiddle AgedInfectious DiseasesTreatment Outcome030220 oncology & carcinogenesis030211 gastroenterology & hepatologyDrug Therapy CombinationFemaleViral loadmedicine.drugAdultmedicine.medical_specialtyDrug-Related Side Effects and Adverse ReactionsGenotypeHepatitis C viruscompassionate useAntiviral Agents03 medical and health sciencesVirologyInternal medicineHumansAdverse effectAgedRetrospective StudiesHepatologybusiness.industryRibavirinparitaprevirHepatitis C Chronicmedicine.diseaseVirologydigestive system diseasesOmbitasvirDiscontinuationombitasvirchemistryParitaprevirSpainhepatitis Cbusiness
researchProduct